BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Roy A, Sahoo J, Narayanan N, Merugu C, Kamalanathan S, Naik D. Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence. World J Diabetes 2021; 12(9): 1426-1441 [PMID: 34630898 DOI: 10.4239/wjd.v12.i9.1426]
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1426.htm
Number Citing Articles
1
Kayo Masuko. Glucose as a Potential Key to Fuel Inflammation in Rheumatoid ArthritisNutrients 2022; 14(11): 2349 doi: 10.3390/nu14112349
2
H. Kang, E. B. Lee, S. Lee, T. ‐H. Go, J. Y. Lee, S. ‐H. Lee, S. A. Song, H. K. Lim, S. ‐P. Hong. Dipeptidyl peptidase‐4 inhibitors increase the risk of bullous pemphigoid in older patients with diabetes: A retrospective analysis using the Korean National Health Insurance DatabaseJournal of the European Academy of Dermatology and Venereology 2023; 37(7) doi: 10.1111/jdv.18975
3
M. Ganeva. SAFETY PROFILE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORSTrakia Journal of Sciences 2023; 21(1): 54 doi: 10.15547/tjs.2023.01.009
4
Grigorios Thermos, Nikolaos Katsoulas, George Vilos, Konstantinos I. Tosios. DPP4‐inhibitor‐associated oral mucous membrane pemphigoidOral Diseases 2023; 29(5): 2321 doi: 10.1111/odi.14234
5
Yuichiro Iwamoto, Takatoshi Anno, Katsumasa Koyama, Fumiko Kawasaki, Kohei Kaku, Koichi Tomoda, Seiko Sugiyama, Yumi Aoyama, Hideaki Kaneto. Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous PemphigoidFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.843480
6
Jie Huang, Xinxin Liu, Yingying Wei, Xinlu Li, Shupei Gao, Lingli Dong, Xiaoquan Rao, Jixin Zhong. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune DiseaseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.830863
7
Khaled R. Alkharsah, Salma Ali Aljaroodi, Jawad Ur Rahman, Awatif N. Alnafie, Reem Al Dossary, Reem Y. Aljindan, Amani M. Alnimr, Jamal Hussen, Ahmed S. Abdel-Moneim. Low levels of soluble DPP4 among Saudis may have constituted a risk factor for MERS endemicityPLOS ONE 2022; 17(4): e0266603 doi: 10.1371/journal.pone.0266603
8
Faten Hadjkacem, Hamdi Frikha, Khouloud Boujelben, Chiraz Chaari, Emna Mnif, Abderrahmen Masmoudi, Tahia Boudawara, Hamida Turki, Mohamed Abid. Bullous Pemphigoid Associated With Dipeptidyl Peptidase-4 Inhibitors: A Case Report and Review of Current EvidenceHospital Pharmacy 2023; 58(4): 357 doi: 10.1177/00185787231151861